These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 12521997)

  • 1. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
    Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
    J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
    Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
    Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.
    Nikolic B; Lee S; Bronson RT; Grusby MJ; Sykes M
    J Clin Invest; 2000 May; 105(9):1289-98. PubMed ID: 10792004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation.
    Tsukada N; Akiba H; Kobata T; Aizawa Y; Yagita H; Okumura K
    Blood; 2000 Apr; 95(7):2434-9. PubMed ID: 10733518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
    Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
    J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles.
    Brocker T; Gulbranson-Judge A; Flynn S; Riedinger M; Raykundalia C; Lane P
    Eur J Immunol; 1999 May; 29(5):1610-6. PubMed ID: 10359115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice.
    Huang Y; Feng S; Tang R; Du B; Xu K; Pan X
    Int J Hematol; 2010 Nov; 92(4):609-16. PubMed ID: 20953915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of OX40/OX40L and CD27/CD70 pathways on allogeneic islet graft rejection.
    Wu T; Hering B; Kirchof N; Sutherland D; Yagita H; Guo Z
    Transplant Proc; 2001; 33(1-2):217-8. PubMed ID: 11266785
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.
    Valzasina B; Guiducci C; Dislich H; Killeen N; Weinberg AD; Colombo MP
    Blood; 2005 Apr; 105(7):2845-51. PubMed ID: 15591118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.
    Ndhlovu LC; Ishii N; Murata K; Sato T; Sugamura K
    J Immunol; 2001 Sep; 167(5):2991-9. PubMed ID: 11509650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
    J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
    Wang HC; Klein JR
    J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
    J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
    J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.